Received Jun 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Administration of Priorix to adult patients; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in an unspecified number of adult patients who received MMR (Priorix) for prophylaxis. On an unknown date, the patients received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration of Priorix to adult patients). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 11-JUN-2025 A sales representative called to transfer over a pharmacist, who informed that lately he had been getting a lot of adult patients that requested vaccination with Priorix in his facility which led to inappropriate age at vaccine administration No more details were provided by reporter.